Clinical Trials Directory

Trials / Unknown

UnknownNCT04487171

Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
248 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum depression, among women who deliver in fourth hospital in the North of France in the context of the COVID epidemy.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireThe mothers were administrated three questionnaires, (i) the Edinburgh Postnatal Depression Scale (EPDS), (ii) the State-Trait Anxiety Inventory (STAI-YA), and (iii) the Mother-to-Infant Bonding Scale (MIBS) in two stages, on days 2-3 after delivery and during a phone call between days 25-35.

Timeline

Start date
2020-07-21
Primary completion
2023-07-01
Completion
2023-08-01
First posted
2020-07-27
Last updated
2023-03-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04487171. Inclusion in this directory is not an endorsement.